Search
Now showing items 1-1 of 1
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Wissenschaftlicher Artikel
(Universität Ulm, 2014)
Now showing items 1-1 of 1